Did you know the risk of c.diff recurrence increases with each episode?

Talk to your doctor to see if ZINPLAVA is right for you.

Learn about access to ZINPLAVA

The Merck Access Program may help answer questions like:

Does my insurance cover ZINPLAVA?
What options may be available for co-pay assistance?

Administration
center locations

Find administration center
locations where ZINPLAVA may
be available.

Patient information

Learn more about ZINPLAVA.

Prescribing
information

Learn more about the
prescribing information for
ZINPLAVA.

What is ZINPLAVA?

ZINPLAVA is a prescription medicine used to help decrease the risk of C. diff (Clostridium difficile infection) from coming back in people aged 18 years or older who are taking an antibiotic for C. diff and who have a high risk of C. diff coming back. ZINPLAVA is not an antibiotic and does not replace the antibiotic.

Important Safety Information

Make sure to tell your doctor if you have or have had congestive heart failure (CHF). Heart failure may happen in people who receive ZINPLAVA and can be serious. People with a history of CHF who received ZINPLAVA had a higher rate of heart failure and death than those who did not receive ZINPLAVA.

The most common side effects that may happen on the day of or the day after receiving ZINPLAVA are nausea, headache, fever, feeling tired, shortness of breath, feeling dizzy, and high blood pressure.

The most common side effects that may happen up to four weeks after receiving ZINPLAVA are nausea, fever, and headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information for ZINPLAVA and discuss it with your doctor.
The physician Prescribing Information also is available.

What is ZINPLAVA (bezlotoxumab)?

ZINPLAVA is a prescription medicine used to help decrease the risk of C. diff (Clostridium difficile infection) from coming back in people aged 18 years or older who are taking an antibiotic for C. diff and who have a high risk of C. diff coming back. ZINPLAVA is not an antibiotic and does not replace the antibiotic.

ZINPLAVA is a prescription medicine used to help decrease the risk of C. diff (Clostridium difficile infection) from coming back in people aged 18 years or older who are taking an antibiotic for C. diff and who have a high risk of C. diff coming back.

ZINPLAVA is a prescription medicine used to help decrease the risk of C. diff (Clostridium difficile infection) from coming back in people aged 18 years or older who are taking an antibiotic for C. diff and who have a high risk of C. diff coming back.

Important Safety Information for ZINPLAVA (bezlotoxumab)

Make sure to tell your doctor if you have or have had congestive heart failure (CHF). Heart failure may happen in people who receive ZINPLAVA and can be serious. People with a history of CHF who received ZINPLAVA had a higher rate of heart failure and death than those who did not receive ZINPLAVA.

The most common side effects that may happen on the day of or the day after receiving ZINPLAVA are nausea, headache, fever, feeling tired, shortness of breath, feeling dizzy, and high blood pressure.

The most common side effects that may happen up to four weeks after receiving ZINPLAVA are nausea, fever, and headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information for ZINPLAVA and discuss it with your doctor.
The physician Prescribing Information also is available.

Make sure to tell your doctor if you have or have had congestive heart failure (CHF).

Make sure to tell your doctor if you have or have had congestive heart failure (CHF). Heart failure may happen in people who receive ZINPLAVA and can be serious. People with a history of CHF who received ZINPLAVA had a higher rate of heart failure and death than those who did not receive ZINPLAVA.